Advertisement
Screener

Oncotelic Therapeutics, Inc. (OTLC) Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number

1.9 / 5 stars · 15/40 Roast Me

Oncotelic Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number

Oncotelic Therapeutics, Inc. (OTLC) reported Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number of 0 shares for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-20.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber · last filed 2021-08-20

  • Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, accelerated vesting, number for the quarter ending 2021-06-30 was 0.00 shares.
  • Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, accelerated vesting, number for the quarter ending 2021-03-31 was 0.00 shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 0 monthShare-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 1 monthShare-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 6 month
2021-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-20
0.00 shares
10-Q · filed 2021-08-20
2021-03-310.00 shares
10-Q · filed 2021-05-24
2019-04-30328.00K shares
10-K · filed 2021-04-15
2019-04-22328.00K shares
10-K · filed 2020-05-14